Jefferies Group Reiterates "Hold" Rating on Johnson & Johnson
's stock had its "hold" rating restated by analysts at Jefferies Group in a research report issued to clients and investors on Wednesday.
Join the discussion below, or Read more at AmericanBankingNews.com.
#1 Jan 22, 2013
Johnson & Johnson has been a major player in the healthcare industry. However, some of their products including their hip replacement devices have been surrounded with safety issues which resulted to thousands of lawsuits filed against the company. We can only hope that those who may have incurred damage receive compensation that they deserve. See http://www.depuyhiprecall.us/updates/depuy-hi... for more related information.
Add your comments below
|FHA Mortgage Focus Fuels Lend America's Rise (Jan '09)||Sep 22||BRIAN FRIED Inven...||835|
|FDA advisors give a thumbs-up to GlaxoSmithKlin...||Sep 14||CONFLICT of INTEREST||1|
|Transgender teenager Jazz Jennings signed to be... (Mar '15)||Aug '17||TipsyFromCentralC...||4|
|PharMerica expects growth after KKR buys it for...||Aug '17||Common_sense||1|
|Appalachian congressmen ask FDA to reclassify O... (May '07)||Aug '17||Viking Power||38|
|Gov't report: Efforts to reduce US uninsured st...||Jul '17||Repeal obama care||23|
|Walgreens and LabCorp Collaborate to Bring Pati...||Jun '17||wagnous||1|
Find what you want!
Search Biotech Forum Now
Copyright © 2017 Topix LLC